A systematic review on serum retinol binding protein 4 (RBP4) and interrelated iron status in type 2 diabetes mellitus patients
Keywords:
Adipokines, RBP4, Insulin Resistance, Iron StatusAbstract
The dysregulation of adipokines is closely associated with the pathogenesis of insulin resistance and type 2 diabetes mellitus. A recently proposed adipokine i.e., Retinol-binding protein-4 (RBP4), is found to provide a connecting link between insulin resistance and obesity. Interestingly, the interaction between vitamin A and iron status has also been observed in a few shreds of evidence. For instance, vitamin A deficiency may result in impairment of iron metabolism and may aggravate anemia. Here, the present review is designed to summarize the up-to-date knowledge on RBP4’s role in obesity, development of insulin resistance, and Type 2 Diabetes Mellitus by findings of previous studies and investigate the crucial possible outcome of the relationship between RBP4 and iron status in type 2 diabetes mellitus patients, most importantly in humans.
Downloads
References
Pamela A, Nankam N, Blüher M. Retinol-binding protein 4 in obesity and metabolic dysfunctions. Molecular and Cellular Endocrinology.2021,531:111312
Comucci EB, Vasques AJ, Geloneze B, Calixto AR, Pareja JC, Tambascia MA. Serum levels of retinol binding protein 4 in women with different levels of adiposity and glucose tolerance. Arq Bras Endocrinol Metab.2014 Oct;58(7):709-14.
Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006; 354:2552–63.
Wang, Y., Sun, L., Lin, X. et al. Retinol binding protein 4 and risk of type 2 diabetes in Singapore Chinese men and women: a nested case-control study. Nutr Metab (Lond. 2019;16,3.
Ge Li, Issy C. Esangbedo, Lu Xu, Junling Fu, Lujiao Li, Dan Feng et al,Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year Risk of insulin resistance and metabolic syndrome: the BCAMS study. Cardiovas diabetol.2018 May;17(1):69.
Y Sowjanya, V Siva Prabodh, D Vidya, Sripad. Role of Iron Metabolic indices in type 2 Diabetes Mellitus. IOSR Journal of Dental and Medical Sciences.2017;16(12):1-5.
Shaabana MA, Alaa Eldeen A Dawod, Mohammed A Nasr. Role of Iron in Diabetes mellitus and its complications. Menoufia Med J. 2016;29(1):11-6.
Fernández-Real JM, Moreno JM and Ricar W. Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance–Associated Iron Overload. Diabetes .2008 Jul;57(7):1918-25.
Sun L, Qi Q, Zong G, Ye X, Li H, Liu X, Zheng H, Frank B, Liu Y, Lin X. Elevated Plasma Retinol-Binding Protein 4 Is Associated with Increased Risk of Type 2 Diabetes in Middle-Aged and Elderly Chinese Adults. The Journal of Nutrition.2014;144(5): 722–28.
Rocchi M, Covone A, Romeo G, Faraonio R, Colantuoni V. Regional mapping of RBP4 to 10q23----q24 and RBP1 to 3q21-q22 in man. Somatic Cell and Molecular Genetics.1989;15(2):185–90
Kanai M, Raz A, Goodman DS. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest.1968;47(9):2025–44.
Naylor MH, M.E. Newcomer ME. The structure of the human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry.1999, 38(9)2647-265
Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356–62.
Ge Li, Issy C. Esangbedo, Lu Xu, Junling Fu, Lujiao Li, Dan Feng et al,Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year Risk of insulin resistance and metabolic syndrome: the BCAMS study. Cardiovas diabetol.2018 May;17(1):69.
Mody N, Graham T.E, Tsuji Y, Yang Q, Kahn B. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am J Physiol Endocrinol Metab. 2008 Apr; 294(4): E785–E793.
Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care. 2006 Nov;29(11):2457-61.
Takebayashi K, Suetsugu M, W Sadao, A Yoshimasa, I Toshihiko. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab.2007 Jul;92(7):2712–9.
Lewis J, Brett I, Chris M, Frampton M, Elder P. Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: A three year longitudinal study. Clinical Biochemistry.2008;41(13):1034-8
Erikstrup C, Mortensen OH, Nielsen AR, Fischer CP, Plomgaard P, Petersen AM, Krogh-Madsen R, Lindegaard B, Erhardt JG, Ullum H, et al. RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes Metab 2009;11(3):204–12.
Ulgen F, Herder C, Kuhn MC, Willenberg HS, Schott M, Scherbaum WA, Schinner S. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Arch Physiol Biochem 2010;116(2):57–62.
Rhie YJ, Choi BM, Eun SH, Son CS, Park SH, Lee KH. Association of Serum Retinol Binding Protein 4 with Adiposity and Pubertal Development in Korean Children and Adolescent. Korean Med Sci.2011; 26:797-802.
Park SE, Lee NS, Park JW, Rhee EJ, Lee WY, Oh KW et al. Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria. European Journal of Endocrinology. 2014;171: 443–9
Khalil HM, Abdalla AE, Shrif SM, Hasani IW. Retinol Binding Protien-4 Levels in Early Diabetic Nephropathy in Egyptian Patients with Type 2 Diabetes. Global J. Biotech. & Biochem.2015;10 (1): 39-46.
Grosjean F, Esposito P, Maccarrone R, Libetta C, Canton AD, Rampino T. RBP4: A Culprit for Insulin Resistance in End Stage Renal Disease That Can Be Cleared by Hemodiafiltration. BioMed Research International.2017; Article ID 7270595, 1-8.
Li JY, Chen XX, Lu XH, Zhang CB, Shi QP, Feng L. Elevated RBP4 plasma levels were associated with diabetic retinopathy in type 2 diabetes. Bioscience Reports. 2018; 38: BSR20181100.
Fan J, Yin S, Lin D, Liu Y, Chen N, Bai X et al. Association of Serum Retinol Binding Protein 4 Levels and the Risk of Incident Type 2 Diabetes in Subjects with Prediabetes. Diabetes Care 2019; 42:1574–1581
Wang Y, Sun L, Lin X, Yuan JM, Koh WP, Pan A. Retinol binding protein 4 and risk of type 2 diabetes in Singapore Chinese men and women: a nested case-control study. Nutrition & Metabolism.2019;16:3.
Tan MI, Hisana AN, Ridwan A, Fitri LL, Fajar PA. Diabetes and Retinol-Binding Protein (RBP4): The Study of Free and Exosomal RBP4 in Blood Plasma and Urine of Patients. Biomed. & Pharmacol. J.2020;13(2), 693-9.
Shaaban MA, Dawod A, Nasr MA. Role of iron in diabetes mellitus and its complications. Menoufia Medical Journal. 2016; 29:11–6.
Dhakad GS, Sharma Ak, Kanwar G, Singh AK, Sharma S. Evaluation of iron profile in type 2 diabetes mellitus patients of tertiary care center of central India. International Journal of Clinical Biochemistry and Research.2019; 6(1):15-19.
Bansal P, Bansal P, Kansal H. Is Serum Ferritin Associated With Type II Diabetes Mellitus: A Clinical Study In A Representative Indian Population. Journal of Medical Science & Research.2011; 2(1):46.
Zhao Z, Li S, Liu G, Yan F, Ma X, Huang Z et al. Body Iron Stores and Heme-Iron Intake in Relation to Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis. A Systematic Review and Meta-Analysis. PLoS ONE 7(7): e4164
Jung CH, Lee MJ, Hwang JY, Jang JE, Leem J, Park JY. Elevated Serum Ferritin Level Is Associated with the Incident Type 2 Diabetes in Healthy Korean Men: A 4 Year Longitudinal Study.2013; PLoS ONE 8(9): e75250.
Liu BW, Xuan XM, Liu J, Li F, Yin FZ. The Relationship between Serum Ferritin and Insulin Resistance in Different Glucose Metabolism in Nonobese Han Adults. International Journal of Endocrinology. 2015; Article ID 642194:5 pages
Misra G, Bhatter SK, Kumar A,Gupta V and Khan MY. Iron Profile and Glycaemic Control in Patients with Type 2 Diabetes Mellitus. Med Sci (Basel). 2016;4(4):22.
Wolide AD, Zawdie B, Alamayehu T, Tadesse S. Evaluation of serum ferritin and some metal elements in type 2 diabetes mellitus patients: comparative cross-sectional study.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2016;9:417–424.
Y Sowjanya, Prabodh S, Vidya D, Sripad. Role of Iron Metabolic indices in type 2 Diabetes Mellitus. IOSR Journal of Dental and Medical Sciences.2017;16(12):1-05.
Kumar S, Badyal A. Serum ferritin levels in Type 2 diabetes mellitus and its relationship with HbA1c. International Journal of Current Advanced Research.2018;7(4):11371-3.
Son NE. Influence of ferritin levels and inflammatory markers on HbA1c in the Type 2 Diabetes mellitus patients. Pak J Med Sci. 2019;35(4):1030-35.
Moirangthem MM, Rajkumari VD. Study of serum ferritin and HbA1c levels in type 2 diabetes mellitus. J. Evid. Based Med. Healthc. 2020; 7(27):1282-85
Sumathi K, Dilliraj G, Shanthi B, Selvi VSK, Rani AJ. Correlation between iron deficiency anemia and HbA1C levels in type 2 diabetes mellitus. Int J Clin Biochem Res. 2020;7(3):400-2.
Michael S, Manjula Devi AJ, Study of Serum Ferritin Levels in Type-2 Diabetes Mellitus. J Res Med Dent Sci.2021;9(5):338-342.
Vasava SN, Sadaria R, Shah T. Effect of Iron Deficiency Anemia on HbA1c Levels in Patients of Diabetes Mellitus with Controlled Plasma Glucose Levels. Indian Journal of Forensic Medicine & Toxicology.April-June 2021;15(2):3493-98.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
